Saturday 23 November 2024
 
»
Tag
 
»
Boehringer Ingelheim

Most type 2 diabetes patients ‘unaware of heart risks’

Seventy-four per cent of patients in the UAE don’t believe that type 2 diabetes is associated with increased cardiovascular risk, said the Emirates Diabetes Society in its findings of a Type 2 Diabetes Patient survey. The su

More…

Boehringer Ingelheim unveils 15 new medicines

Boehringer Ingelheim, a family-owned pharmaceutical company, recently unveiled 15 new medicines could potentially be approved by 2025 in immunology, CNS, oncology, respiratory and cardio metabolic diseases.   The company pres

More…

Boehringer Ingelheim adds Merial to animal health unit

Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, has announced that Merial, a leading animal health company, has become part of the Boehringer Ingelheim organisation.   “We have united

More…

Boehringer Ingelheim names Mideast head

Boehringer Ingelheim, a leading German pharmaceutical company, has appointed Enrique Manzoni as its country managing director for the region. Manzoni will lead the overall operations in the Middle East, Turkey and Africa region ba

More…

Boehringer Ingelheim names Mideast head

Boehringer Ingelheim, a leading German pharmaceutical company, has appointed Enrique Manzoni as its country managing director for the region. Manzoni will lead the overall operations in the Middle East, Turkey and Africa region ba

More…

Boehringer Ingelheim opens new office in Kuwait

Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, recently opened its new office in Kuwait. The opening ceremony was held in YIACO Medical Company’s (YIACO) headquarters, in Salmiya, and where

More…

Saudi German Hospital opens new stroke unit

Saudi German Hospital (SGH) Riyadh, one of the largest private hospitals with a capacity of 300 beds, recently its first stroke unit in partnership with Boehringer Ingelheim, a top pharmaceutical company. The stroke unit, which is

More…

Boehringer Ingelheim introduces new treatment options for cancer

Boehringer Ingelheim, a leading pharmaceutical company, recently presented its new treatment for epidermal growth factor receptor (EGFR) mutation positive non-small cell lung cancer (NSCLC) at an educational session held in Dubai, UAE.

More…

Boehringer launches stroke management academy

Germany-based Boehringer Ingelheim, a leading pharmaceutical company, has launched an academy to establish comprehensive stroke management protocol in the region. The first of its kind introduced in the region, the Stroke Academy

More…

Hikma acquires assets of US pharma group

Hikma Pharmaceuticals, a leading medical group in the region, has signed an agreement with Boehringer Ingelheim Group of Companies to acquire the assets of Bedford Laboratories for $300 million. Hikma is a fast growing multination

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads